REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Desitin Pharma SRL (Romania)

Main Activities: Administrative Management and General Management Consulting Services
Full name: Desitin Pharma SRL Profile Updated: November 13, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Desitin Pharma SRL is a company in Romania, with a head office in Bucharest. It operates in the Administrative Management and General Management Consulting Services industry. The company was established on January 11, 2010. It currently has a total number of 11 (2024) employees. There was a net sales revenue increase of 15.66% reported in Desitin Pharma SRL’s latest financial highlights for 2024. Its’ total assets recorded a growth of 2.92%. Desitin Pharma SRL’s net profit margin decreased by 6.35% in 2024.

Headquarters
Strada Sevastopol Nr. 13
Bucharest; Bucharest;

Contact Details: Purchase the Desitin Pharma SRL report to view the information.

Basic Information
Total Employees:
Purchase the Desitin Pharma SRL report to view the information.
Registered Capital:
Purchase the Desitin Pharma SRL report to view the information.
Financial Auditors:
Purchase the Desitin Pharma SRL report to view the information.
Incorporation Date:
January 11, 2010
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Desitin Pharma SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
15.66%▲
Total operating revenue
18.52%▲
Operating profit (EBIT)
-45.24%▼
EBITDA
-19.88%▼
Net Profit (Loss) for the Period
-75.58%▼
Total Assets
2.92%▲
Total Equity
1.27%▲
Operating Profit Margin (ROS)
-5.62%▼
Net Profit Margin
-6.35%▼
Return on Equity (ROE)
-4.02%▼
Quick Ratio
-27.75%▼
Cash Ratio
-11.41%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo